- Switching to Aflibercept in Diabetic Macular Edema after Unsatisfactory Response to Other Anti-vascular Endothelial Growth Factor Drugs
-
Ibrahim WS, Eldaly ZH, Saleh MG, Rateb MF, Aldoghaimy AH
- KMID: 2442616
- Korean J Ophthalmol.
- 2019 Apr;33(2):122-130.
- doi: 10.3341/kjo.2018.0037
PURPOSE: To evaluate the efficacy of switching to aflibercept in diabetic macular edema (DME) with suboptimal response to previous anti-vascular endothelial growth factor (anti-VEGF) injections. METHODS: A prospective interventional case series... -
- CITED
-
- Close
- SHARE
-
- Close
